Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1111 AL 1125

Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in Japan

Taomoto D, Sato S, Kanemoto H, Suzuki M, Hirakawa N, Takasaki A, Akimoto M, Satake Y, Koizumi F, Yoshiyama K, Takahashi R, Shigenobu K, Hashimoto M, Miyagawa T, Boeve B, Knopman D, Mori E, Ikeda M.

Psychogeriatrics. 2024 Mar;24(2):281-294. doi: 10.1111/psyg.13072. Epub 2023 Dec 28.

Alzheimer's disease and Alzheimer's disease-related dementias in Hispanics: Identifying influential factors and supporting caregivers

Rawat P, Sehar U, Bisht J, Reddy AP, Reddy PH.

Ageing Res Rev. 2024 Jan;93:102178. doi: 10.1016/j.arr.2023.102178. Epub 2023 Dec 27.

Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhai Z, Kong F, Zhu Z, Dai J, Cai J, Xie D, Shen Y, Xu Y, Sun T.

Am J Geriatr Psychiatry. 2024 May;32(5):555-583. doi: 10.1016/j.jagp.2023.11.011. Epub 2023 Dec 7.

Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets

Vakili O, Asili P, Babaei Z, Mirahmad M, Keshavarzmotamed A, Asemi Z, Mafi A.

CNS Neurol Disord Drug Targets. 2023;22(9):1335-1354. doi: 10.2174/1871527321666220829164211.

Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

Groot C, Smith R, Stomrud E, Binette AP, Leuzy A, Wuestefeld A, Wisse LEM, Palmqvist S, Mattsson-Carlgren N, Janelidze S, Strandberg O, Ossenkoppele R, Hansson O.

Brain. 2023 Apr 19;146(4):1580-1591. doi: 10.1093/brain/awac329.

Ocular Biomarkers for Alzheimer Disease Dementia: An Umbrella Review of Systematic Reviews and Meta-analyses

Costanzo E, Lengyel I, Parravano M, Biagini I, Veldsman M, Badhwar A, Betts M, Cherubini A, Llewellyn DJ, Lourida I, MacGillivray T, Rittman T, Tamburin S, Tai XY, Virgili G.

JAMA Ophthalmol. 2023 Jan 1;141(1):84-91. doi: 10.1001/jamaophthalmol.2022.4845.

Plasma biomarkers for neurodegenerative disorders: ready for prime time?

Balogun WG, Zetterberg H, Blennow K, Karikari TK.

Curr Opin Psychiatry. 2023 Mar 1;36(2):112-118. doi: 10.1097/YCO.0000000000000851. Epub 2023 Jan 16.

Shaping the risk for late-life neurodegenerative disease: A systematic review on prenatal risk factors for Alzheimer's disease-related volumetric brain biomarkers

Boots A, Wiegersma AM, Vali Y, van den Hof M, Langendam MW, Limpens J, Backhouse EV, Shenkin SD, Wardlaw JM, Roseboom TJ, de Rooij SR.

Neurosci Biobehav Rev. 2023 Mar;146:105019. doi: 10.1016/j.neubiorev.2022.105019. Epub 2023 Jan 3.

ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan

Siemers E, Hitchcock J, Sundell K, Dean R, Jerecic J, Cline E, Iverson K, Moore J, Edgar C, Manber R, Fuin N, Poppe T, Barton R.

J Prev Alzheimers Dis. 2023;10(1):19-24. doi: 10.14283/jpad.2022.93.

Imaging Amyloid and Tau in the Retina: Current Research and Future Directions

Tang MY, Blazes MS, Lee CS.

J Neuroophthalmol. 2023 Jun 1;43(2):168-179. doi: 10.1097/WNO.0000000000001786. Epub 2023 Feb 3.

Association between anxiety symptoms and Alzheimer's disease biomarkers in cognitively healthy adults: A systematic review and meta-analysis

Demnitz-King H, Saba L, Lau Y, Munns L, Zabihi S, Schlosser M, Del-Pino-Casado R, Orgeta V, Marchant NL.

J Psychosom Res. 2023 Mar;166:111159. doi: 10.1016/j.jpsychores.2023.111159. Epub 2023 Jan 20.

A novel regulator in Alzheimer's disease progression: The astrocyte-derived extracellular vesicles

Li B, Ma Z, Li Z.

Ageing Res Rev. 2023 Apr;86:101871. doi: 10.1016/j.arr.2023.101871. Epub 2023 Feb 2.

Scientific, Ethical, and Practical Considerations for the Testing and Disclosure of Alzheimer Disease Biomarkers

McCusker EA, Loy CT.

Neurology. 2023 May 23;100(21):993-994. doi: 10.1212/WNL.0000000000207199. Epub 2023 Feb 15.

Challenges and opportunities of diagnostic markers of Alzheimer's disease based on structural magnetic resonance imaging

Hu X, Meier M, Pruessner J.

Brain Behav. 2023 Mar;13(3):e2925. doi: 10.1002/brb3.2925. Epub 2023 Feb 16.

CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab

Nisenbaum L, Martone R, Chen T, Rajagovindan R, Dent G, Beaver J, Rubel C, Racine A, He P, Harrison K, Dean R, Vandijck M, Haeberlein SB.

Alzheimers Dement. 2023 Aug;19(8):3379-3388. doi: 10.1002/alz.12919. Epub 2023 Feb 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias